Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Z Takácsi-Nagy
Cetuximab and Platinum-Based Chemoradio- Or Chemotherapy of Patients With Epidermal Growth Factor Receptor Expressing Adenoid Cystic Carcinoma: A Phase II Trial
British Journal of Cancer
Cancer Research
Oncology
Related publications
Randomized, Phase II Study of the Insulin-Like Growth Factor-1 Receptor Inhibitor IMC-A12, With or Without Cetuximab, in Patients With Cetuximab- Or Panitumumab-Refractory Metastatic Colorectal Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Phase II Trial of Anti-Epidermal Growth Factor Receptor Radioimmunotherapy in the Treatment of Anaplastic Astrocytoma
Journal of Radiation Oncology
Oncology
Radiology
Nuclear Medicine
Imaging
Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients With No Evidence of Disease Progression After First-Line Platinum-Based Chemotherapy
Targeted Oncology
Cancer Research
Oncology
Pharmacology
Phase II Study of Gefitinib in Patients With Relapsed or Persistent Ovarian or Primary Peritoneal Carcinoma and Evaluation of Epidermal Growth Factor Receptor Mutations and Immunohistochemical Expression: A Gynecologic Oncology Group Study
Clinical Cancer Research
Cancer Research
Oncology
Adenoid Cystic Carcinoma
Contemporary Neurosurgery
Treatment of High-Grade Glioma Patients With the Humanized Anti-Epidermal Growth Factor Receptor (EGFR) Antibody H-R3: Report From a Phase I/Ii Trial
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Phase II Trial of Sunitinib Maintenance Therapy After Platinum-Based Chemotherapy in Patients With Extensive-Stage Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Adenoid Cystic Carcinoma
Oral Surgery, Oral Medicine, Oral Pathology
Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology